EUVIMEDEUVIMED entdecken
Crossref

Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease

Jill S Menell iD, S Raelle Jackson, Alissa R Kahn, William C Woolbright, Leya Y Schwartz, John Norko

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Jill S Menell und 5 weiteren Autor:innen. Beteiligte Einrichtung: St. Joseph's Children's Hospital, Paterson, New Jersey, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Hydroxyurea, Duffy Blood-Group System, Antisickling Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Duffy null phenotype is common in people of African ancestry and is associated with lower baseline white blood cell (WBC) and neutrophil counts. We evaluated whether the presence of the Duffy null phenotype had any association with neutropenia in our patients with sickle cell disease on hydroxyurea (HU). We found a statistically significant difference ( p = 0.006) in HU maximum tolerated dose (MTD) in patients with Duffy null phenotype compared with Duffy‐positive individuals. Our study suggests that careful dose escalation is warranted in Duffy‐null individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellHydroxyureaDuffy Blood-Group SystemAntisickling AgentsReceptors, Cell SurfaceHumansChildFemaleMaleAdolescentChild, PreschoolNeutropeniaMaximum Tolerated DosePrevalence

Substanzen

HydroxyureaDuffy Blood-Group SystemAntisickling AgentsACKR1 protein, humanReceptors, Cell Surface

Autor:innen und Institutionen

  • St. Joseph's Children's Hospital, Paterson, New Jersey, USA.
  • St. George's University School of Medicine, True Blue, Grenada.

ORCID-Profile: Jill S Menell

Zitieren

APA

Menell, J. S., Jackson, S. R., Kahn, A. R., Woolbright, W. C., Schwartz, L. Y., & Norko, J. (2025). Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31693

Vancouver

Menell JS, Jackson SR, Kahn AR, Woolbright WC, Schwartz LY, Norko J. Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31693

BibTeX
@article{Menell2025,
  author = {Menell, Jill S and Jackson, S Raelle and Kahn, Alissa R and Woolbright, William C and Schwartz, Leya Y and Norko, John},
  title = {Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31693}
}
Kostenlos starten →